Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06394232
What this trial is testing

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

Who this might be right for
Retinal DiseaseMacular DegenerationAge-Related Macular Degeneration+2 more
Eyestem Research Pvt. Ltd. 54
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Large-scale testing (Phase 3)Ended earlyNCT00890097
What this trial is testing

Geographic Atrophy Treatment Evaluation

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Alcon Research 772
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705568
What this trial is testing

An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy

Who this might be right for
Geographic AtrophyAge - Related Macular Degeneration (AMD)
Eyevensys 24
Not applicableNot Yet RecruitingNCT07570355
What this trial is testing

Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Shanghai Institute of Acupuncture, Moxibustion and Meridian 62
Not applicableStudy completedNCT02227498
What this trial is testing

Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol

Who this might be right for
Age Related Macular Degeneration
Second Sight Medical Products 5
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Not applicableUnknownNCT06264947
What this trial is testing

Efficacy of Laser Acupuncture on Zanzhu (BL02) for Dry Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
China Medical University Hospital 30
Early research (Phase 1)Study completedNCT07024732
What this trial is testing

A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration

Who this might be right for
Dry Age Related Macular Degeneration
Eyevensys 8
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Large-scale testing (Phase 3)Study completedNCT04435366
What this trial is testing

Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Who this might be right for
Geographic AtrophyMacular Degeneration
IVERIC bio, Inc. 448
Not applicableEnded earlyNCT02399072
What this trial is testing

Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 202
Testing effectiveness (Phase 2)Study completedNCT00940407
What this trial is testing

Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
Merry, Graham, M.D. 18
Early research (Phase 1)Study completedNCT04744662
What this trial is testing

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
ONL Therapeutics 28
Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Not applicableStudy completedNCT06381596
What this trial is testing

Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
University of Wisconsin, Madison 32
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Looking for participantsNCT07215234
What this trial is testing

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Sanofi 104
Early research (Phase 1)WithdrawnNCT01093170
What this trial is testing

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Mark Kleinman
Next Page